Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.
2.
3.

Diabetic dyslipidemia.

Kreisberg RA.

Am J Cardiol. 1998 Dec 17;82(12A):67U-73U; discussion 85U-86U. Review.

PMID:
9915665
4.

Role of fibric acid derivatives in the management of risk factors for coronary heart disease.

Després JP, Lemieux I, Robins SJ.

Drugs. 2004;64(19):2177-98. Review.

PMID:
15456334
5.

Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.

Chapman MJ, Guérin M, Bruckert E.

Eur Heart J. 1998 Feb;19 Suppl A:A24-30. Review.

PMID:
9519339
6.

Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.

Quaschning T, Krane V, Metzger T, Wanner C.

Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S14-9. Review.

PMID:
11576915
7.

Interrelationship of triglycerides with lipoproteins and high-density lipoproteins.

Gotto AM Jr.

Am J Cardiol. 1990 Sep 4;66(6):20A-23A. Review.

PMID:
2203246
8.

Obesity and Dyslipidemia.

Feingold KR, Grunfeld C.

In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2015 Jun 12.

Items per page

Supplemental Content

Write to the Help Desk